Clinical trials
COVID clinical trials
Below are recruiting covid clinical trials, each written for real people, not researchers. We’re tracking 369 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06441955RecruitingPhase 4
Long Covid prevention and health support trial
This trial tests a care program designed to help people who continue to have symptoms after recovering from COVID-19. It aims to prevent long-term health problems and improve well-being.
Bethesda, MarylandAges 18–65 - NCT06456502Recruiting
Non-invasive brain stimulation for long COVID symptoms
This trial tests whether a gentle, non-invasive brain stimulation device can help relieve long COVID symptoms. It involves wearing special gloves and socks that deliver mild electrical pulses to improve how you feel.
Alcorcón, MadridAges 18 years+ - NCT06492798RecruitingPhase 1/Phase 2
Stem cells for Long COVID: a safety and effectiveness study
This study tests whether a single infusion of mesenchymal stem cells can help with Long COVID symptoms—without causing serious side effects. It’s for people who are still struggling with COVID-related health problems months after their initial infection.
ShanghaiAges 18–70 - NCT06614309Recruiting
Non-invasive treatment for brain fog from long COVID
This study tests a non-invasive treatment to help with brain fog caused by long COVID. It may improve your symptoms if you have trouble thinking clearly or focusing.
Scottsdale, ArizonaAges 18 years+ - NCT06631287RecruitingPhase 3
Testing baricitinib for persistent long COVID symptoms
This trial tests whether the anti-inflammatory drug baricitinib can improve persistent long COVID symptoms like brain fog, fatigue, and shortness of breath. You may qualify if you had COVID-19 at least 6 months ago and still have bothersome symptoms that affect your daily life.
Tucson, ArizonaAges 18 years+ - NCT06672692Recruiting
Study of a new test for flu, RSV, and COVID-19 in people with symptoms
This trial evaluates a new test that can detect flu A/B, RSV, and COVID-19 from a single nose swab. It is for people who are currently sick with respiratory symptoms and are either hospitalized, in the ER, visiting a clinic, or living in a long-term care facility.
Henderson, NevadaAges Any age - NCT06776263Recruiting
Breathing problems after COVID-19 study
This study looks at people who have ongoing breathing issues after a COVID-19 infection. It tests a simple questionnaire to see if you have dysfunctional breathing (abnormal breathing patterns) and may help guide treatment.
Stockholm, SolnaAges 18 years+ - NCT06821113Recruiting
COVID-19 prevention program for Latino day laborers
This trial tests a program adapted for Latino day laborers to help prevent COVID-19. It aims to see if the program works for people who look for work at street corners.
Houston, TexasAges 18 years+ - NCT06825819Recruiting
Dysbiosis and long COVID study
This study looks at gut bacteria changes in people with and without long COVID symptoms after a confirmed COVID infection. It may help find why some people have long-term health problems.
Chicago, IllinoisAges 18–80 - NCT06864156Recruiting
Molecules and vitamin levels in long COVID with brain fog
This study looks at certain molecules (called microRNAs) and vitamin B12 levels in people who have ongoing brain-related symptoms like depression, anxiety, or fatigue after a COVID-19 infection. It may help understand why some people have long-lasting symptoms and could lead to better treatments.
Mexico City, Mexico CityAges 18–65 - NCT06927622Recruiting
COVID-19 study for pregnant women and infants
This study follows pregnant women and their babies to learn more about COVID-19 and how it affects them. By taking part, you help researchers understand the virus and improve care for mothers and children.
Jinan, ShandongAges 18 years+ - NCT06928272RecruitingPhase 3
Long COVID drug study for adults 18 to 65
This study tests whether a commonly used drug (repurposed) can help improve Long COVID symptoms like fatigue, breathing problems, or brain fog. It is for adults 18 to 65 who had COVID-19 in the past 4 years and still have symptoms after 3 months.
San Diego, CaliforniaAges 18–65 - NCT06960928RecruitingPhase 3
Low dose sirolimus for long COVID
This trial tests if a low dose of sirolimus, a medicine that calms the immune system, can help people with long COVID. If you have had long COVID symptoms for at least 6 months, like severe fatigue, brain fog, or chest pain, you may be able to join.
New York, New YorkAges 18 years+ - NCT06968442Recruiting
Obesity and severe COVID-19 study
This study looks at how obesity affects the body's response to severe COVID-19. It compares people with obesity to healthy-weight healthcare workers to understand differences in the immune system.
Rotterdam, South HollandAges 18–65 - NCT07134673Recruiting
Long COVID and cell energy study
This study looks at how cells make energy in people with Long COVID compared to people who fully recovered. It involves a blood draw, a small muscle sample, and a skin biopsy to understand why symptoms last.
Jette, Brussels CapitalAges 18 years+ - NCT07154199Recruiting
Ultrasound for brain fog after COVID-19
This trial tests if gentle ultrasound waves to the head can help clear brain fog that lasts after a COVID-19 infection. If you've had COVID and still feel mentally slow or forgetful, this treatment might help your thinking get sharper.
Beijing, Beijing MunicipalityAges 18–75 - NCT07295483Recruiting
Long COVID 4-Year Follow-Up Study
This study follows up with people who already took part in the BioICOPER study to see how long COVID symptoms and health evolve over 4 years. If you were in that earlier study, you may join this one to help researchers learn more about long-term recovery.
Salamanca, SalamancaAges 18 years+ - NCT02735707RecruitingPhase 3
Adaptive trial for severe pneumonia care in intensive care
This study tests ways to improve treatment for adults with severe pneumonia that lands them in the ICU, adjusting the plan as results come in. It may help your care team find better treatments for lung infection and breathing/heart support needs.
Jacksonville, FloridaAges 18 years+ - NCT07445971RecruitingPhase 1
Study of MDX2301 for healthy adults and those at higher risk for severe COVID-19
This trial tests an investigational drug called MDX2301 to see if it's safe in healthy adults and in adults who are at higher risk for severe COVID-19. Higher risk means you have conditions like asthma, diabetes, heart disease, or other listed health issues.
Las Vegas, NevadaAges 18–64 - NCT05890612Recruiting
Study of Paxlovid safety and effectiveness in high-risk COVID-19
This study observes people at higher risk for severe COVID-19 who take Paxlovid, to better understand how well it works and how safe it is in real-world use. It may help doctors confirm the best way to use Paxlovid and spot any side effects.
SeoulAges 19 years+ - NCT07013474RecruitingPhase 3
Study of ibuzatrelvir for immunocompromised adults with COVID-19
This trial tests an investigational medicine called ibuzatrelvir for adults with COVID-19 who have a weakened immune system. The study aims to see if it helps them recover and avoid severe illness.
Canoga Park, CaliforniaAges 18 years+ - NCT07730450RecruitingPhase 4
COVID-19 vaccine study for healthy adults aged 18 to 64
This trial tests a COVID-19 vaccine in healthy adults to see how well it works. It may be an option if you are not at higher risk for severe COVID-19 and have not had COVID-19 in the past 6 months.
Walnut Creek, CaliforniaAges 18–64 - NCT06156254Recruiting
Community help to get updated COVID-19 vaccine
This trial is testing a community-based program to help people get the most updated COVID-19 booster. It's for adults who've had a previous COVID-19 vaccine but not the latest one, and who also have a chronic health condition (like high blood pressure, diabetes, asthma, obesity, or a mental health condition).
Brooklyn, New YorkAges 18 years+ - NCT05805566Recruiting
Study of care for long COVID symptoms in adults
This study follows people who enter a specialized care pathway for long COVID (post-COVID syndrome) to better understand symptoms, needs, and outcomes. It may help improve how multidisciplinary care is organized for long COVID over time.
Pierre-BéniteAges 18 years+
Hear when a new COVID trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for covid?
- Yes. Clin2 currently lists 369 recruiting covid studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a covid trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a covid trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.